| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
The Patient Marketing Group is a Pennington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Merrill Gardens LLC is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Chester River Health System is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Chestertown, MD. To find more information about Chester River Health System, please visit www.chesterriverhealth.org
Iberia Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Iberia Medical Center is based in New Iberia, LA. You can find more information on Iberia Medical Center at www.iberiamedicalcenter.com